McCaughan G - Search Results

1

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.

Bishop DC, Clancy LE, Simms R, Burgess J, Mathew G, Moezzi L, Street JA, Sutrave G, Atkins E, McGuire HM, Gloss BS, Lee K, Jiang W, Maddock K, McCaughan G, Avdic S, Antonenas V, O'Brien TA, Shaw PJ, Irving DO, Gottlieb DJ, Blyth E, Micklethwaite KP. Bishop DC, et al. Among authors: mccaughan g. Blood. 2021 Oct 21;138(16):1504-1509. doi: 10.1182/blood.2021010813. Blood. 2021. PMID: 34010392 Free article. Clinical Trial. No abstract available.

2

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

Jiang W, Clancy LE, Avdic S, Sutrave G, Street J, Simms R, McGuire HM, Patrick E, Chan AS, McCaughan G, Myers N, Micklethwaite KP, Antonenas V, Selim AG, Ritchie D, Bateman CM, Shaw PJ, Blyth E, Gottlieb DJ. Jiang W, et al. Among authors: mccaughan g. Blood Adv. 2022 Sep 13;6(17):4949-4966. doi: 10.1182/bloodadvances.2022007103. Blood Adv. 2022. PMID: 35819448 Free PMC article.

3

Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia.

McCaughan G, Ma D, Moore J. McCaughan G, et al. Bone Marrow Transplant. 2021 Feb;56(2):514-516. doi: 10.1038/s41409-020-01025-8. Epub 2020 Aug 8. Bone Marrow Transplant. 2021. PMID: 32772047 No abstract available.

4

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.

Banerjee R, Wang B, Anderson LD Jr, McCaughan G, Mehra N, Cowan AJ, Rajkumar SV, Kaur G. Banerjee R, et al. Among authors: mccaughan g. Blood Cancer J. 2023 Nov 6;13(1):162. doi: 10.1038/s41408-023-00937-0. Blood Cancer J. 2023. PMID: 37926718 Free PMC article. No abstract available.

5

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.

Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD Jr, Cowan AJ, Rajkumar SV, Kaur G. Hoff FW, et al. Among authors: mccaughan g. Blood Cancer J. 2024 Mar 22;14(1):52. doi: 10.1038/s41408-024-01034-6. Blood Cancer J. 2024. PMID: 38519476 Free PMC article.

6

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.

Di Ciaccio P, McCaughan G, Trotman J, Ho PJ, Cheah CY, Gangatharan S, Wight J, Ku M, Quach H, Gasiorowski R, Polizzotto MN, Prince HM, Mulligan S, Tam CS, Gregory G, Hapgood G, Spencer A, Dickinson M, Latimer M, Johnston A, Armytage T, Lee C, Cochrane T, Berkhahn L, Weinkove R, Doocey R, Harrison SJ, Webber N, Lee HP, Chapman S, Campbell BA, Gibbs SDJ, Hamad N. Di Ciaccio P, et al. Among authors: mccaughan g. Intern Med J. 2020 Jun;50(6):667-679. doi: 10.1111/imj.14859. Epub 2020 May 15. Intern Med J. 2020. PMID: 32415723

7

An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly.

Blennerhassett R, McCaughan G, Tegg E. Blennerhassett R, et al. Among authors: mccaughan g. Pathology. 2018 Dec;50(7):773-775. doi: 10.1016/j.pathol.2018.05.007. Epub 2018 Sep 28. Pathology. 2018. PMID: 30274817 No abstract available.

8

Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres.

McCaughan GJ, Verma A, Ling S, Lavee O, Moore JJ, Bryant A. McCaughan GJ, et al. Bone Marrow Transplant. 2021 Mar;56(3):738-740. doi: 10.1038/s41409-020-01086-9. Epub 2020 Oct 19. Bone Marrow Transplant. 2021. PMID: 33077903 No abstract available.

9

Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.

Withers B, McCaughan G, Hayward C, Kotlyar E, Jabbour A, Rainer S, De Angelis E, Horvath N, Milliken S, Dogan A, MacDonald P, Moore J. Withers B, et al. Among authors: mccaughan g. Intern Med J. 2022 Jan;52(1):69-78. doi: 10.1111/imj.15072. Intern Med J. 2022. PMID: 32981138

10

Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review.

McCaughan GJ, Gandolfi S, Moore JJ, Richardson PG. McCaughan GJ, et al. Br J Haematol. 2022 Oct;199(2):190-204. doi: 10.1111/bjh.18295. Epub 2022 Jul 7. Br J Haematol. 2022. PMID: 35796524 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

601 results

Search Page